Corporate News 31-May-22
Board of Marksans Pharma recommends final dividend
Of Rs 0.25 per share
Marksans Pharma announced that the Board of Directors of the Company at its meeting held on 30 May 2022, inter alia, have recommended the final dividend of Rs 0.25 per equity Share (i.e. 25%) , subject to the approval of the shareholders.
Previous News
Marksans Pharma declare Quarterly Result
( Corporate News - 13-May-24 15:04 )
Marksans Pharma to table results
( Corporate News - 31-Jul-24 14:13 )
Marksans Pharma's Goa unit concludes USFDA inspection with observations
( Corporate News - 18-Apr-24 11:45 )
Marksans Pharma gets UK MHRA approval for Fluoxetine oral solution
( Hot Pursuit - 23-Jan-23 13:30 )
Marksans Pharma receives affirmation in credit ratings
( Corporate News - 07-Feb-23 12:46 )
Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
( Corporate News - 23-Jan-23 13:41 )
Marksans Pharma to announce Quarterly Result
( Corporate News - 27-Oct-21 10:53 )
Marksans Pharma to consider buyback
( Corporate News - 05-Jul-22 09:52 )
Marksans Pharma to discuss results
( Corporate News - 17-May-22 11:10 )
Marksans Pharma Ltd leads gainers in 'A' group
( Hot Pursuit - 05-Jul-22 12:00 )
Marksans Pharma schedules board meeting
( Corporate News - 24-May-21 12:55 )
Other Stories
Board of NRB Bearings recommends interim dividend
05-Oct-24 09:27
Refex Industries to hold EGM
05-Oct-24 09:26
Allcargo Terminals to hold EGM
05-Oct-24 09:26
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Back
Top
